Yeshiva University: Vitamin C Increases Immunotherapy's Anti-Cancer Effects
January 29, 2020
January 29, 2020
BRONX, New York, Jan. 29 [TNSmedicalresearch] -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
Recently introduced cancer immunotherapies unleash patients' immune systems to attack cancers. In a study published online on January 7 in Proceedings of the National Academy of Sciences, senior author Niraj Shenoy, M.D., M.S., and collaborators report that combining high-dose ascorbic acid (vitamin C) with a class of immunotherapies called ant . . .
Recently introduced cancer immunotherapies unleash patients' immune systems to attack cancers. In a study published online on January 7 in Proceedings of the National Academy of Sciences, senior author Niraj Shenoy, M.D., M.S., and collaborators report that combining high-dose ascorbic acid (vitamin C) with a class of immunotherapies called ant . . .